Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2014: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
Significance of ARID1A (one of the chromatin remodeling gene) in gastric cancer was analyzed in each subtype of gastric cancer (EBV, MSI-H, and the others). Using gastric cancer cell lines, mRNA microarray revealed expression of genes related to cell proliferation or cell cycle are frequently altered by knockdown of ARID1A. Knockdown of ARID1A suppressed proliferation of gastric cancer cell lines in MTT assay. Knockdown of one gene which is overexpressed by knockdown of ARID1A resulted in decrease of infection efficiency of EBV into gastric cancer cell lines. The result indicates the importance of ARID1A in the establishment of EBV-associated gastric cancer.
|